JACC-Journal of the American College of Cardiology美国心脏病学会杂志

JACC-Journal of the American College of Cardiology(英文缩写 J AM COLL CARDIOL),ISSN 0735-1097,eISSN 1558-3597,中文译名:美国心脏病学会杂志 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。

2026 年数据 · 影响因子
22.300
JCR 分区
Q1
CAS 分区
B1
近一年发文量
847
本站 PubMed 收录统计

发文量统计区间:2025-11-01 至 2026-10-31,按本站收录文献的发表日期统计。

ISSN: 0735-1097 · eISSN: 1558-3597 · 缩写: J AM COLL CARDIOL ·中文: 美国心脏病学会杂志

期刊介绍

选择期刊介绍栏目

期刊简介

JACC(Journal of the American College of Cardiology)是美国心脏病学会的旗舰期刊,长期位居心血管医学领域顶级学术刊物之列。该刊发表覆盖临床心脏病学各分支的高影响力研究,包括缺血性心脏病、心力衰竭、心律失常、结构性心脏病、预防与流行病学等,读者群主要为心血管专科医师、介入与影像专家、临床研究者及转化医学团队。

研究方向

主要方向涵盖临床心血管试验、注册研究与观察性队列、诊断与治疗新技术、指南与共识文件、心血管影像与生物标志物等。论文类型以原创研究、随机对照试验、系统综述与荟萃分析、最新临床试验报告及编辑评论为主,兼顾基础与转化研究,强调对临床实践和学科发展具有直接推动作用。

期刊特色

研究取向偏重多中心、大样本和临床终点证据,重视方法学严谨性与结果的可推广性。论文通常要求明确的临床问题、充分的统计分析和清晰的实践启示。适合已有较成熟数据体系、希望影响指南与临床决策的心血管研究者、临床团队及公共卫生学者阅读和投稿。

投稿难度

投稿难度整体较高,竞争激烈,对创新性、样本规模、终点设计和统计严谨性要求严格。准备时应突出临床意义与增量价值,完善预设分析方案和敏感性分析,规范报告国际指南要求,并重视与既往文献的差异化定位;不宜仅凭分区或指标判断录用可能性。

历年影响因子趋势

JCR 数据年份影响因子JCR 分区
202127.206Q1
202224.000Q1
202321.700Q1
202422.300Q1
202522.300Q1

JACC-Journal of the American College of Cardiology 最新收录文献

  1. JCR分区: Q1 CAS分区: B1 影响因子: 22.3

    1. Optimizing Blood Pressure Care in Patients With Resistant Hypertension: 2026 ACC Expert Consensus Decision Pathway: A Report of the American College of Cardiology Solution Set Oversight Committee.

    1. 优化难治性高血压患者的血压管理:2026年ACC专家共识决策路径:美国心脏病学会解决方案监督委员会报告
    作者:
    Leslie L Davis, Eugene Yang, Ciantel Adair Blyler, Jennifer L Cluett, Jordana B Cohen, Stephen P Juraschek, John P Reilly, Kardie Tobb
    日期:
    2026-10-05

    该文献暂无摘要。

  2. JCR分区: Q1 CAS分区: B1 影响因子: 22.3

    2. Food and Health: Nutrition for Prevention and Management of Cardiovascular Disease: 2026 ACC Scientific Statement: A Report of the American College of Cardiology.

    2. 食品与健康:心血管疾病预防和管理的营养策略:2026年美国心脏病学会科学声明:美国心脏病学会报告
    作者:
    Frank B Hu, Branko Beleslin, Michael J Blaha, Penny M Kris-Etherton, Hilary K Seligman, Kim Allan Williams
    日期:
    2026-09-30

    Nutrition is a foundational determinant of cardiovascular health and a central component of the prevention and management of cardiovascular disease, type 2 diabetes, obesity, chronic kidney disease, and cardiovascular-kidney-metabolic syndrome. Suboptimal dietary patterns remain among the leading modifiable causes of morbidity and mortality worldwide. Contemporary evidence supports a shift in nutrition guidance from isolated nutrients toward whole foods and dietary patterns that emphasize overall dietary quality, food choice, and degree of processing. This American College of Cardiology Scientific Statement reviews current evidence regarding nutrition and cardiovascular health, including macronutrients, micronutrients, dietary patterns, ultra-processed foods, and emerging nutrition-based interventions. Evidence from randomized controlled trials, prospective cohort studies, and mechanistic investigations consistently supports replacing saturated fats with unsaturated fats, increasing consumption of dietary fiber and whole grains, reducing consumption of sodium and ultra-processed foods (particularly sugar-sweetened beverages and processed meats), and greater adherence to healthy dietary patterns to lower cardiovascular risk. Mediterranean, DASH (Dietary Approaches to Stop Hypertension), vegetarian, and other plant-rich dietary patterns demonstrate favorable effects on blood pressure, lipids, glycemic control, and body weight, and are consistently associated with lower rates of cardiovascular disease and mortality. Translation of nutrition science into clinical practice requires integration of dietary counseling, medical nutrition therapy, Food Is Medicine programs, public policy initiatives, and clinician education. Collectively, current evidence supports dietary patterns centered on minimally processed plant foods while limiting ultra-processed foods, particularly those high in refined starches, added sugars, sodium, or unhealthy fats, and emphasizing healthy sources of fats and proteins to reduce cardiovascular risk and improve population health.

  3. JCR分区: Q1 CAS分区: B1 影响因子: 22.3

    3. The End of "Cardiac Clearance": Patient-Centered Care in Preoperative Cardiovascular Risk Assessment.

    3. “心脏许可”的终结:以患者为中心的术前心血管风险评估
    作者:
    Mary Norine Walsh
    日期:
    2026-09-29

    该文献暂无摘要。

  4. JCR分区: Q1 CAS分区: B1 影响因子: 22.3

    4. 2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

    4. 2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM非心脏手术围手术期心血管管理指南:美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
    作者:
    Annemarie Thompson, Kirsten E Fleischmann, Nathaniel R Smilowitz, Lisa de Las Fuentes, Debabrata Mukherjee, Niti R Aggarwal, Faraz S Ahmad, Robert B Allen, S Elissa Altin, Andrew Auerbach, Jeffrey S Berger, Benjamin Chow, Habib A Dakik, Eric L Eisenstein, Marie Gerhard-Herman, Kamrouz Ghadimi, Bessie Kachulis, Jacinthe Leclerc, Christopher S Lee, Tracy E Macaulay, Gail Mates, Geno J Merli, Purvi Parwani, Jeanne E Poole, Michael W Rich, Kurt Ruetzler, Steven C Stain, Bobbie Jean Sweitzer, Amy W Talbot, Saraschandra Vallabhajosyula, John Whittle, Kim Allan Williams
    日期:
    2026-09-29

    The "2026 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery" provides recommendations to guide clinicians in the perioperative cardiovascular evaluation and management of adult patients undergoing noncardiac surgery. A comprehensive literature search was conducted from August 2022 to March 2023 to identify clinical studies, reviews, and other evidence conducted on human subjects that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Recommendations from the "2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery" have been updated with new evidence consolidated to guide clinicians; clinicians should be advised this guideline supersedes the previously published 2014 guideline. In addition, evidence-based management strategies, including pharmacological therapies, perioperative monitoring, and devices, for cardiovascular disease and associated medical conditions, have been developed.

  5. JCR分区: Q1 CAS分区: B1 影响因子: 22.3

    5. Lymphatic Interventions for Protein-Losing Enteropathy: New Frontier or Last-Ditch Therapy?

    5. 淋巴介入治疗用于蛋白丢失性肠病:新前沿还是最后手段?
    作者:
    Stephan J Wu, Surendranath R Veeram Reddy
    日期:
    2026-09-29

    该文献暂无摘要。

  6. JCR分区: Q1 CAS分区: B1 影响因子: 22.3

    6. Advancing Hemodynamic Understanding in High-Risk PCI: A Critical Appraisal of the CHIP-BCIS3 Hemodynamic Substudy.

    6. 推进高危PCI中的血流动力学理解:对CHIP-BCIS3血流动力学子研究的批判性评价
    作者:
    Daniel Burkhoff, Mir Babar Basir, Jeffrey J Popma, Ajay J Kirtane
    日期:
    2026-09-29

    该文献暂无摘要。

  7. JCR分区: Q1 CAS分区: B1 影响因子: 22.3

    7. Beyond Information Asymmetry in Medicine: The Changing Nature of Medical Authority and Expertise.

    7. 超越医学中的信息不对称:医学权威与专业知识的性质变迁
    作者:
    Harlan M Krumholz
    日期:
    2026-09-29

    该文献暂无摘要。

  8. JCR分区: Q1 CAS分区: B1 影响因子: 22.3

    8. The Return on Mentorship.

    8. 导师制的回报
    作者:
    Harlan M Krumholz
    日期:
    2026-09-22

    该文献暂无摘要。

  9. JCR分区: Q1 CAS分区: B1 影响因子: 22.3

    9. Back to the Basics to BRIDGE Guideline-Directed Care.

    9. 回归基础,衔接指南导向的护理
    作者:
    Carl Hashem, Salim S Virani, Nathan D Wong, Eugenia Gianos
    日期:
    2026-09-18

    该文献暂无摘要。

  10. JCR分区: Q1 CAS分区: B1 影响因子: 22.3

    10. Evaluating Intracoronary Imaging-Guided PCI: Balancing Evidence Synthesis and Exploration of Heterogeneity.

    10. 评估冠状动脉内成像引导的PCI:平衡证据综合与异质性探索
    作者:
    Ibrahim Halil Tanboga, Sanjay Kaul
    日期:
    2026-09-17

    该文献暂无摘要。

在 JACC-Journal of the American College of Cardiology 中搜索更多文献

支持中英文检索 · 智能翻译 · 影响因子 · PDF 下载 · AI 文献阅读

指标接近的期刊